Abstract
Objectives
To investigate risk factors associated with right paraesophageal lymph node (RPELN) metastasis in patients with papillary thyroid carcinoma (PTC) and to determine the indications for right lymph node dissection.
Methods
Clinicopathologic data from 829 patients (104 men and 725 women) with PTC, operated on by the same thyroid surgery team at the First Affiliated Hospital of Harbin Medical University from January 2013 to May 2017, were analyzed. Overall, 309 patients underwent total thyroidectomy with bilateral lymph node dissection, 488 underwent right thyroid lobe and isthmic resection with right central compartment lymph node dissection, and 32 underwent near-total thyroidectomy (ipsilateral thyroid lobectomy with contralateral near-total lobectomy) with bilateral lymph node dissection.
Results
The overall rate of central compartment lymph node metastasis was 43.5% (361/829), with right central compartment lymph node and RPELN metastasis rates of 35.5% (294/829) and 19.1% (158/829), respectively. Tumor size, number, invasion, and location, lymph node metastasis, right central compartment lymph node metastasis, and right lateral compartment lymph node metastasis were associated with RPELN in the univariate analysis, whereas age and sex were not. Multivariate analysis identified tumors with a diameter ≥ 1 cm, multiple tumors, tumors located in the right lobe, right central compartment lymph node metastasis, and right lateral compartment lymph node metastasis as independent risk factors for RPELN metastasis.
Conclusions
Lymph node dissection, including RPELN dissection, should be performed for patients with PTC with a tumor diameter ≥ 1 cm, multiple tumors, right-lobe tumors, right central compartment lymph node metastasis, or suspected lateral compartment lymph node metastasis.
Similar content being viewed by others
Abbreviations
- OR:
-
Odds ratio
- CI:
-
Confidence interval
- PTC:
-
Papillary thyroid carcinoma
- RPELN:
-
Right paraesophageal lymph node
- rCLN:
-
Right central compartment lymph node
- LLN:
-
Lateral compartment lymph node
References
Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER cancer statistics review, 1975-2013, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016
Jung KW, Won YJ, Kong HJ et al (2014) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat 46:109–123. https://doi.org/10.4143/crt.2014.46.2.109
Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A National cancer data base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995 [see comments]. Cancer 83:2638–2648
Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214. https://doi.org/10.1089/thy.2009.0110
Gimm O, Rath FW, Dralle H (1998) Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 85:252–254. https://doi.org/10.1046/j.1365-2168.1998.00510.x
Machens A, Hinze R, Thomusch O, Dralle H (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26:22–28. https://doi.org/10.1007/s00268-001-0176-3
Russo M, Malandrino P, Moleti M et al (2017) Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods. J Endocrinol Invest 40:1235–1241. https://doi.org/10.1007/s40618-017-0688-9
Pinyi Z, Bin Z, Jianlong B et al (2014) Risk factors and clinical indication of metastasis to lymph nodes posterior to right recurrent laryngeal nerve in papillary thyroid carcinoma: a single-center study in China. Head Neck 36:1335–1342. https://doi.org/10.1002/hed.23451
Yuan J, Li J, Chen X et al (2017) Predictors of lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid carcinoma: a retrospective study. Med 96:e7908. https://doi.org/10.1097/md.0000000000007908
Castagna MG, Cantara S, Pacini F (2016) Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients. J Endocrinol Invest 39:1087–1094. https://doi.org/10.1007/s40618-016-0503-z
Pacini F, Brianzoni E, Durante C et al (2016) Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology. J Endocrinol Invest 39:341–347. https://doi.org/10.1007/s40618-015-0375-7
Ito Y, Kudo T, Kobayashi K et al (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5768 patients with average 10-year follow-up. World J Surg 36:1274–1278. https://doi.org/10.1007/s00268-012-1423-5
Gao M, Ge M, Ji Q et al (2017) 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma. Cancer Biol Med 14:203–211. https://doi.org/10.20892/j.issn.2095-3941.2017.0051
Lee BJ, Lee JC, Wang SG et al (2009) Metastasis of right upper para-esophageal lymph nodes in central compartment lymph node dissection of papillary thyroid cancer. World J Surg 33:2094–2098. https://doi.org/10.1007/s00268-009-0149-5
Bae SY, Yang JH, Choi MY et al (2012) Right paraesophageal lymph node dissection in papillary thyroid carcinoma. Ann Surg Oncol 19:996–1000. https://doi.org/10.1245/s10434-011-2144-y
Kim YS, Park WC (2012) Clinical predictors of right upper paraesophageal lymph node metastasis from papillary thyroid carcinoma. World J Surg Oncol 10:164. https://doi.org/10.1186/1477-7819-10-164
Ito Y, Fukushima M, Higashiyama T et al (2013) Incidence and predictors of right paraesophageal lymph node metastasis of N0 papillary thyroid carcinoma located in the right lobe. Endocr J 60:389–392
Zhang L, Liu H, Xie Y et al (2016) Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma. Eur J Surg Oncol 42:81–86. https://doi.org/10.1016/j.ejso.2015.10.011
Liu Z, Sun M, Xiao Y et al (2017) Predictors of metastasis to lymph nodes posterior to the right recurrent laryngeal nerve in differentiated thyroid carcinoma: a prospective study. Asian J Surg 40:270–277. https://doi.org/10.1016/j.asjsur.2015.12.003
Park YM, Lee SM, Kim DW et al (2017) Predictive factors of right paraesophageal lymph node metastasis in papillary thyroid carcinoma: single center experience and meta-analysis. PLoS One 12:e0177956. https://doi.org/10.1371/journal.pone.0177956
Glattre E, Kravdal O (1994) Male and female parity and risk of thyroid cancer. Int J Cancer 58:616–617
Sapuppo G, Palermo F, Russo M et al (2017) Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome. J Endocrinol Invest 40:1355–1363. https://doi.org/10.1007/s40618-017-0714-y
Shattuck TM, Westra WH, Ladenson PW, Arnold A (2005) Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med 352:2406–2412. https://doi.org/10.1056/NEJMoa044190
Park SY, Park YJ, Lee YJ et al (2006) Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci. Cancer 107:1831–1838. https://doi.org/10.1002/cncr.22218
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests or financial interest invested in this work.
Ethical approval
This study was approved by the ethics committee of First Ailiated Hospital of Harbin Medical University. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Yu, Q.A., Ma, D.K., Liu, K.P. et al. Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma. J Endocrinol Invest 41, 1333–1338 (2018). https://doi.org/10.1007/s40618-018-0874-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-018-0874-4